NOL3
NOL3 (nucleolar protein 3), also known as ARC, NOP30, MYP and CARD2, is an anti-apoptotic protein that blocks several modes of cell death. It acts on both extrinsic and intrinsic apoptotic pathways and on TNF-induced necrosis. Browse Assay Genie's current range of NOL3 research reagents below, or read on for the biology behind the target.
NOL3 functions as an apoptosis repressor and restrains cell death through several distinct mechanisms. In the extrinsic pathway it interacts with FAS and FADD after FAS activation, blocking assembly of the death-inducing signalling complex (DISC). It also interacts with CASP8 in a manner dependent on mitochondrial localisation and phosphorylation, limiting the soluble CASP8 available for DISC-mediated activation. In the intrinsic pathway, NOL3 interacts with BAX, inactivating it and preventing mitochondrial dysfunction and the release of pro-apoptotic factors.
The protein also acts as a cytosolic calcium buffer, helping to maintain calcium homeostasis and inhibiting calcium-mediated cell death. It negatively regulates oxidative stress-induced apoptosis through phosphorylation-dependent suppression of the mitochondrial pathway, blocking CASP2 activation and BAX translocation. Under hypoxia, it limits apoptosis in part by inhibiting cytochrome c release from mitochondria in a caspase-independent manner. NOL3 additionally inhibits TNF-induced necrosis by interacting with TNFRSF1A, which prevents RIPK1 recruitment to complex I. Through its anti-apoptotic role it promotes vascular remodelling in response to hypoxia by inhibiting apoptosis and stimulating proliferation, and it inhibits myoblast differentiation through caspase inhibition. NCBI Gene notes that it down-regulates the enzymatic activities of caspase 2, caspase 8 and tumour protein p53.
The NOL3 gene belongs to the caspase recruitment domain (CARD) containing gene group. Its previous HGNC name was nucleolar protein 3 (apoptosis repressor with CARD domain), which explains the alias ARC. UniProt records localisation to the nucleolus, cytoplasm, mitochondrion, sarcoplasmic reticulum and membrane, and multiple transcript variants encoding different isoforms have been described. Mouse and rat both carry a Nol3 ortholog.
NOL3 blocks DISC assembly through FAS and FADD and limits CASP8 activation, making it a useful node for studying extrinsic cell death.
By interacting with BAX and limiting cytochrome c release, NOL3 is studied in intrinsic apoptosis and mitochondrial integrity.
NOL3 suppresses hypoxia-induced apoptosis and promotes vascular remodelling by inhibiting apoptosis and stimulating proliferation.
NOL3 inhibits TNF-induced necrosis via TNFRSF1A and acts as a cytosolic calcium buffer, supporting work on non-apoptotic cell death.
NOL3 is an apoptosis repressor. It blocks death-inducing signalling complex assembly, limits CASP8 availability, inactivates BAX, buffers cytosolic calcium and prevents TNF-induced necrosis by interfering with RIPK1 recruitment to complex I. It also inhibits myoblast differentiation through caspase inhibition.
NOL3 is also called ARC, NOP30, MYP and CARD2. Its earlier HGNC name was nucleolar protein 3 (apoptosis repressor with CARD domain). NCBI Gene reports multiple transcript variants that encode different isoforms.
Yes. Orthologs named Nol3 are annotated in both mouse and rat, so rodent models are commonly used to study its anti-apoptotic roles. Check the datasheet of any product for its validated reactivity.
Caspases, death receptor components and cell death regulators that act in pathways alongside NOL3.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O60936; product specifications from Assay Genie datasheets.